Maravai LifeSciences Inc... (MRVI)
NASDAQ: MRVI
· Real-Time Price · USD
2.62
0.02 (0.77%)
At close: Aug 15, 2025, 3:59 PM
2.62
0.19%
After-hours: Aug 15, 2025, 06:49 PM EDT
Maravai LifeSciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 47.4M | 46.85M | 56.41M | 65.2M | 73.4M | 64.18M | 74.14M | 66.86M | 68.91M | 79.03M | 204.71M | 191.26M | 242.73M | 244.29M | 228.44M | 204.81M | 217.78M | 148.21M |
Cost of Revenue | 39.63M | 39.13M | 37.44M | 36.83M | 38.27M | 45.2M | 35.71M | 36.69M | 43.27M | 33.68M | 53.25M | 38.18M | 37.5M | 40.03M | 39.14M | 32.05M | 37.51M | 30.37M |
Gross Profit | 7.77M | 7.72M | 18.96M | 28.37M | 35.13M | 18.98M | 38.43M | 30.18M | 25.64M | 45.35M | 151.46M | 153.09M | 205.24M | 204.26M | 189.31M | 172.76M | 180.26M | 117.84M |
Operating Income | -66.28M | -49.16M | -38.13M | -169.11M | -9.51M | -18.86M | 213K | -15.42M | -11.61M | -2.16M | 109.25M | 116.9M | 180.7M | 167.37M | 154.54M | 156.87M | 154.25M | 92.44M |
Interest Income | 3.03M | 3.23M | 6.04M | 7.07M | 7.09M | 7.21M | 7.46M | 7.43M | 6.79M | 6.04M | 2.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -74.13M | -52.69M | -46.5M | -175.64M | -16.93M | -22.41M | 656.19M | -20.56M | -13.36M | -4.52M | 95.88M | 113.76M | 174.99M | 166.84M | 144.69M | 151.65M | 145.73M | 89.56M |
Net Income | -39.59M | -29.95M | -26.14M | -99.04M | -7.58M | -12.08M | -105.96M | -6.46M | -6.54M | -1.35M | 87.43M | 99.65M | 156.72M | 146.86M | 55.83M | 54.27M | 49.08M | 23.25M |
Selling & General & Admin | 38.58M | 39.56M | 41.24M | 39.09M | 40.56M | 31.2M | 33.63M | 38.86M | 35.38M | 38.67M | 37.2M | 30.8M | 28.06M | 33.2M | 25.58M | 25.19M | 24.09M | 23.24M |
Research & Development | 4.88M | 4.89M | 4.56M | 4.34M | 5.28M | 5.03M | 4.59M | 4.35M | 4.19M | 4.14M | 5.01M | 5.39M | 4.27M | 3.69M | 9.18M | 1.95M | 1.93M | 2.16M |
Other Expenses | 30.59M | 12.44M | 11.29M | 154.06M | -1.2M | n/a | n/a | 2.38M | n/a | 168K | n/a | -4K | n/a | 7K | 201K | 78K | -3K | 3K |
Operating Expenses | 74.05M | 56.89M | 57.09M | 197.49M | 44.64M | 36.23M | 38.22M | 45.6M | 39.57M | 42.82M | 42.21M | 36.18M | 32.34M | 36.9M | 34.77M | 27.14M | 26.02M | 25.4M |
Interest Expense | 6.82M | 6.78M | 11.26M | 13.63M | 11.94M | 10.86M | 15.4M | 11.64M | 7.02M | 11.83M | 10.18M | 3.14M | 4.43M | 2.66M | 7.02M | 7.68M | 7.65M | 7.9M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 113.67M | 96.01M | 94.54M | 234.31M | 82.91M | 83.04M | 73.93M | 82.28M | 82.84M | 76.49M | 95.47M | 74.36M | 69.83M | 76.93M | 73.9M | 59.19M | 63.53M | 55.77M |
Income Tax Expense | -4.29M | 162K | -7K | 311K | -2.44M | 271K | 766.17M | -5.46M | -1.42M | -3.17M | 8.45M | 14.11M | 18.27M | 19.98M | 17.58M | 18.84M | 11.39M | 13.71M |
Shares Outstanding (Basic) | 144.24M | 143.43M | 141.81M | 141.56M | 135.84M | 132.33M | 132.14M | 131.93M | 131.86M | 131.74M | 131.63M | 131.54M | 131.5M | 131.5M | 131.46M | 118.43M | 112.2M | 96.65M |
Shares Outstanding (Diluted) | 144.24M | 143.43M | 139.73M | 141.56M | 135.84M | 132.33M | 132.14M | 131.93M | 131.86M | 131.74M | 131.65M | 131.65M | 121.97M | 121.97M | 121.97M | 121.97M | 112.28M | 96.67M |
EPS (Basic) | -0.27 | -0.21 | -0.18 | -0.7 | -0.06 | -0.09 | -0.8 | -0.05 | -0.05 | -0.01 | 0.66 | 0.76 | 1.19 | 1.12 | 0.42 | 0.46 | 0.44 | 0.24 |
EPS (Diluted) | -0.27 | -0.21 | -0.18 | -0.7 | -0.06 | -0.09 | -0.8 | -0.05 | -0.05 | -0.01 | 0.66 | 0.76 | 1.28 | 1.20 | 0.42 | 0.44 | 0.44 | 0.24 |
EBITDA | -66.28M | -49.16M | -20.71M | -147.97M | 9.56M | 2.21M | 684.57M | 4.17M | 5.46M | 18.22M | 114.14M | 126.81M | 188.34M | 178.76M | 157.11M | 167.27M | 161.58M | 105.22M |
EBIT | -67.31M | -45.91M | -35.24M | -162.01M | -4.99M | -11.54M | 671.59M | -8.93M | -6.34M | 2.53M | 106.06M | 116.9M | 179.43M | 169.5M | 148.25M | 160.2M | 154.24M | 98.33M |
Depreciation & Amortization | n/a | 14.91M | 14.53M | 14.04M | 14.55M | 13.75M | 12.98M | 13.1M | 11.8M | 10.91M | 8.2M | 9.91M | 8.91M | 9.26M | 5.4M | 7.08M | 7.34M | 6.89M |